| Source NDC Code |
|
Target HCPCS Code |
66302-0206-03
TYVASO (4X2.9ML) 0.6 MG/1 ML
|
⇄
|
J7686
TREPROSTINIL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE FORM, 1.74 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
2.9 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
PC |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
66302-0206-03
TYVASO 0.6 MG/ML
|
⇄
|
J7699
NOC DRUGS, INHALATION SOLUTION ADMINISTERED THROUGH DME
|
| Detail Information |
| Relationship Start Date |
8/14/2009 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
SOL |
| Route Of Administration |
IH |
| Billing Units |
ML |
|
|
|
66302-0206-03
TYVASO
|
⇄
|
J7686
Treprostinil, non-comp unit
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|